Akums Drugs Board to Consider Q2 Results on 2nd Nov'26
Akums Drugs and Pharmaceuticals Ltd 路 Intimation 路 02 Nov 2026, 5:30 am
Akums Drugs Board to Consider Q2 Results on 2nd Nov'26 Akums Drugs and Pharmaceuticals Ltd has scheduled a Board of Directors meeting on 2nd Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for company securities remains closed and will reopen 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Akums Drugs and Pharmaceuticals Ltd
- Intimation of Schedule of the Investors/Analysts Meet 路 10 Nov 2026
- Transcript of the Earning/Quarterly Conference Call on the unaudited financial results for the quarter and half year ended on September 30, 2026 路 05 Nov 2026
- Audio recording of Earning/ Quarterly Conference Call 路 03 Nov 2026
- Newspaper Publication 路 03 Nov 2026
- Final Report of CRISIL Ratings Limited, Monitoring Agency 路 03 Nov 2026
- Q2 FY 2026-27 - Investor Presentation 路 02 Nov 2026
- Press Release 路 02 Nov 2026
- Mr. Sanjay Kumar has been designated as Senior Management Personnel of the Company. 路 02 Nov 2026
